1995
DOI: 10.1002/hup.470100212
|View full text |Cite
|
Sign up to set email alerts
|

Severe bradycardia following fluoxetine administration: A case report in a young HIV‐1 infected woman

Abstract: Some reports in the literature suggest that fluoxetine can produce bradycardia in elderly people or in subjects with cardiovascular diseases, thus indicating that the drug should be used with caution in this kind of patient. The aim of this case report is to notify that the same adverse effect could be found in HIV-I infected patients. The HIV-1 infected patient we describe is a young woman not affected by cardiovascular pathologies who nevertheless developed severe bradycardia following fluoxetine administrat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

1997
1997
1997
1997

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 10 publications
1
0
0
Order By: Relevance
“…Our findings also show that paroxetine is a welltolerated drug. The adverse effects reported in this study belong to the well-known adverse effects profile of paroxetine, as derived from extensive studies performed in the general population; in particular, w e did not find rare or paradoxical adverse effects, as have been reported in connection with the use of other drugs, such as fluvoxamine and fluoxetine, in HIV-infected people (Grusi and Scarone, 1994;Grassi et al, 1995a;Grassi e t al.. 1995b).…”
Section: Discussionsupporting
confidence: 62%
“…Our findings also show that paroxetine is a welltolerated drug. The adverse effects reported in this study belong to the well-known adverse effects profile of paroxetine, as derived from extensive studies performed in the general population; in particular, w e did not find rare or paradoxical adverse effects, as have been reported in connection with the use of other drugs, such as fluvoxamine and fluoxetine, in HIV-infected people (Grusi and Scarone, 1994;Grassi et al, 1995a;Grassi e t al.. 1995b).…”
Section: Discussionsupporting
confidence: 62%